sb 220025 has been researched along with quinoxalines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murray, HJ; O'Connor, JJ | 1 |
1 other study(ies) available for sb 220025 and quinoxalines
Article | Year |
---|---|
A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dentate Gyrus; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Imidazoles; In Vitro Techniques; Isoenzymes; Long-Term Synaptic Depression; Male; Mitogen-Activated Protein Kinases; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Quinoxalines; Rats; Rats, Wistar; Sulfonamides; Time Factors | 2003 |